DURECT CORP (16) | Intellectual Property (4)
- License agreement by and between the Company and Innocoll Pharmaceuticals Limited dated December 21, 2021 (Filed With SEC on March 8, 2022)
- Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018 (Filed With SEC on November 3, 2021)
- Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015 (Filed With SEC on November 3, 2021)
- License Agreement between the Company and Gilead Sciences, Inc. dated July 19, 2019 (Filed With SEC on November 5, 2019)
